Introduction

Acquired frailty in the Intensive Care Unit (ICU) (ICUAW) is a frailty condition that affects critically ill patients during their long-term stay in the intensive care unit (ICU). These patients are characterized by decreased muscle strength and respiratory dysfunction. They often have impaired cough reflexes and have difficulty clearing respiratory secretions. Qijia Medical's innovative cough relief devices offer a non-invasive and efficient solution to address these challenges, reducing complications and improving the treatment outcomes for patients.

---

Understand the acquired weaknesses in the icu

ICUAW is caused by prolonged inactivity, critical illness or mechanical ventilation, resulting in respiratory muscle weakness. Due to ineffective coughing, patients with ICUAW are at high risk of mucus retention, atelectasis and pneumonia. Although the traditional method of suctioning phlegm is useful, it can cause airway trauma and discomfort. This highlights the demand for safer and more effective alternatives, such as QIJIA's cough relief device.

---

The working principle of the Qijia Cough Relief Device

This device adopts mechanical inspiration-exhalation MIE technology and simulates the natural cough mechanism through a two-stage cycle:

1. Inflation stage: Provide controlled positive pressure to expand the lungs and relax the secretions in the lower respiratory tract.

2. Expiratory period: It rapidly turns to negative pressure, generating airflow that causes secretions to flow upward in the respiratory tract, facilitating their expulsion.

This physiological method can ensure deep airway clearance in non-invasive surgery.

---

The clinical efficacy of the Qijia Cough Relief Auxiliary Device

1. Highly effective in clearing phlegm

This device can effectively remove deep secretions and reduce the risk of mucus retention and infection. Its non-invasive design minimizes the complications associated with manual sputum aspiration.

2. Improve respiratory function

By keeping the airways unobstructed, this device enhances oxygen exchange, reduces carbon dioxide retention, and supports overall respiratory health.

3. Reduce reliance on mechanical ventilation

Studies have shown that the active use of MI-E treatment in ICU or home care Settings can prevent intubation, shorten ventilation time, and improve the outcome after extubation.

4. Enhance patient comfort

Compared with traditional methods, this operation is painless and well tolerated, significantly improving the comfort of patients.

5. Accelerate lung recovery

In addition to removing secretions, this device also helps with lung dilation exercises, prevents atelectasis, and promotes a faster recovery of function.

---

Key precautions for Safe use

Although QIJIA's cough assistance device is transformative, its application needs to comply with safety protocols:

• Personalized Settings: Adjust pressure parameters according to the individual needs of patients.

• Continuous monitoring: Clinicians must monitor vital signs in real time and adjust treatment plans accordingly.

• Contraindications:

- Absolute: Pneumothorax, acute lung injury (ALI/ARDS), hemodynamic instability.

- Relative: Recent meals, the patient's non-cooperation or tracheal softening.

---

"Conclusion

QIJIA's cough assistance device has completely transformed the ICU care for ICUAW patients, providing a safe, efficient and patient-centered solution for airway management. By reducing infections, shortening ICU stays and promoting recovery, it enables clinicians to provide higher-quality care while prioritizing patient comfort.

Key words: ICU-acquired weakness, QIJIA cough assist Device, Mechanical inflation-exhalation, Airway Clearance, Respiratory Therapy, Innovation in ICU Care